Yinsha Miao

Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Efficacy and impact of hypocrellin B-mediated antimicrobial photodynamic therapy against biofilms of Candida albicans.

Efficacy and impact of hypocrellin B-mediated antimicrobial photodynamic therapy against biofilms of Candida albicans.

Journal: Antonie van Leeuwenhoek
Published: August 10, 2025

A Probiotic Approach Targeting Hypersialylation Revives CD8+ T-cell Immunity and Boosts Photodynamic Therapy Efficacy in Solid Tumors.

A Probiotic Approach Targeting Hypersialylation Revives CD8+ T-cell Immunity and Boosts Photodynamic Therapy Efficacy in Solid Tumors.

Journal: Cancer research
Published: July 15, 2025

RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia.

RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia.

Journal: eLife
Published: July 26, 2024

Peritoneal B1 and B2 cells respond differently to LPS and IL-21 stimulation.

Peritoneal B1 and B2 cells respond differently to LPS and IL-21 stimulation.

Journal: Molecular immunology
Published: December 05, 2023

Unlocking PD-1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression.

Unlocking PD-1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression.

Journal: Scandinavian journal of immunology
Published: July 07, 2023

Activation-induced cytidine deaminase displays an alternative co-factor for modulating PIM1 expression in diffuse large B cell lymphoma cell lines.

Activation-induced cytidine deaminase displays an alternative co-factor for modulating PIM1 expression in diffuse large B cell lymphoma cell lines.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: July 01, 2022

lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.

lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.

Journal: International journal of oncology
Published: May 30, 2021

Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AID.

Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AID.

Journal: Blood advances
Published: April 20, 2021

RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.

RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.

Journal: Cancer science
Published: January 12, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026